therapies. Hormone-independent tumors are more aggressive Stephen H.Safe 3 and development of clinical protocols for treatment of these more highly invasive breast tumors is a major challenge mented by in vivo studies that show that TCDD inhibits TCDD and related compounds also caused a 50% inhibition formation of spontaneous mammary tumors in 2-year-old of cell growth, which resembled the growth inhibitory female Sprague-Dawley rats and growth of 7,12-dimethyleffects previously reported for epidermal growth factor (EGF). However, EGF expression is minimal in this cell benzanthracene-induced mammary tumors in rats; moreover, line and is not induced by TCDD; moreover, EGF and TCDD inhibits growth of mammary tumors in immuno-TCDD induced a different pattern of oncogene expression suppressed B6D2F1 mice bearing MCF-7 cell xenografts and and apoptosis in MDA-MB-468 cells. In contrast, TCDD treated with E2 (25-27). The high toxicity of TCDD would caused a rapid and sustained induction of transforming preclude its use as a drug for treatment of mammary cancer; growth factor α (TGFα) gene expression and secreted however, several relatively non-toxic alkylated polychlorinated protein (nearly 2-fold); moreover, the growth-inhibitory dibenzofurans appear to be potentially useful as chemoeffects of TCDD could be blocked by antibodies to the therapeutic agents (28-32). EGF receptor. In a separate experiment, it was shown that TCDD and related compounds bind to the aryl hydrocarbon TGFα also inhibited growth of MDA-MB-468 cells. The (Ah) receptor, which is expressed in various organs and tissues results of this study indicate that the mechanism of growth including breast tumors and cancer cell lines (14). There is inhibition of MDA-MB-468 cells by TCDD is due to strong evidence that supports a role for the Ah receptor in induction of TGFα, which is a potent antimitogen in this mediating the anti-estrogenic activity of TCDD; however, cell breast cancer line.
mented by in vivo studies that show that TCDD inhibits TCDD and related compounds also caused a 50% inhibition formation of spontaneous mammary tumors in 2-year-old of cell growth, which resembled the growth inhibitory female Sprague-Dawley rats and growth of 7,12-dimethyleffects previously reported for epidermal growth factor (EGF). However, EGF expression is minimal in this cell benzanthracene-induced mammary tumors in rats; moreover, line and is not induced by TCDD; moreover, EGF and TCDD inhibits growth of mammary tumors in immuno-TCDD induced a different pattern of oncogene expression suppressed B6D2F1 mice bearing MCF-7 cell xenografts and and apoptosis in MDA-MB-468 cells. In contrast, TCDD treated with E2 (25-27). The high toxicity of TCDD would caused a rapid and sustained induction of transforming preclude its use as a drug for treatment of mammary cancer; growth factor α (TGFα) gene expression and secreted however, several relatively non-toxic alkylated polychlorinated protein (nearly 2-fold); moreover, the growth-inhibitory dibenzofurans appear to be potentially useful as chemoeffects of TCDD could be blocked by antibodies to the therapeutic agents (28) (29) (30) (31) (32) . EGF receptor. In a separate experiment, it was shown that TCDD and related compounds bind to the aryl hydrocarbon TGFα also inhibited growth of MDA-MB-468 cells. The (Ah) receptor, which is expressed in various organs and tissues results of this study indicate that the mechanism of growth including breast tumors and cancer cell lines (14) . There is inhibition of MDA-MB-468 cells by TCDD is due to strong evidence that supports a role for the Ah receptor in induction of TGFα, which is a potent antimitogen in this mediating the anti-estrogenic activity of TCDD; however, cell breast cancer line.
there are several possible mechanistic pathways (14) . For example, recent studies have shown that inhibition of E2-induced cathepsin D gene expression involves interaction of Introduction the nuclear Ah receptor complex with an inhibitory dioxin response element (iDRE) located in the 5Ј-flanking region of The growth of human breast tumors is dependent on several this gene (22). The anti-estrogenic and antimitogenic activity factors including their hormone or estrogen-responsiveness of TCDD has primarily been established in ER-positive cell and expression of the estrogen receptor (ER*) and other gene lines, since these cells express a functional Ah receptor as products. Many estrogen-responsive tumors are initially treated evidenced by induction of CYP1A1 gene expression by TCDD with anti-estrogens; however, these tumors often progress to and related compounds in these cells (33) (34) (35) (36) (37) (38) (39) . In contrast, hormone-independence and become resistant to endocrine limited studies with ER-negative cell lines such as Hs578T and MDA-MB-231 cells, indicate that these cells are Ah-non- were treated with 0.1% DMSO. Cells were incubated for 2 h at 37°C with for Cell Biology (Essen, Germany). The hER expression plasmid contains the shaking, and then centrifuged and washed (two times) with 20 ml HEGD full length hER cDNA and was a generous gift from Dr Ming Jer Tsai, Baylor buffer. The washed cell pellet was resuspended in 1 ml of HED buffer (HEGD College of Medicine (Houston, TX). HE19 and HE15 plasmids express the buffer without glycerol) and incubated on ice for 10 min. Re-pelleted cells ER truncated in the N-terminal (amino acids 1 to 178 deleted) and C-terminal were resuspended in 1 ml HEGD buffer, homogenized, washed with HEGD (amino acids 282 to 595 deleted) ends, respectively. These expression plasmids buffer, and pelleted by centrifugation. The resulting nuclear pellet was then were kindly provided by Professor P.Chambon (University of Strasbourg, resuspended in extraction buffer (HEGD buffer plus 0.5 M KCl), and incubated Strasbourg, France). Arnt and Ah receptor genes were provided by Dr for 1 h at 4°C. After centrifugation, the supernatant nuclear extracts were C.Bradfield (Northwestern University, Chicago, IL) and Dr O.Hankinson aliquotted and stored at -80°C until used. Protein concentrations were then (UCLA, Los Angeles, CA), respectively, and were constructed into pcDNA1 determined (46) . and pcDNA3 vectors, respectively, for expression. cDNAs for Northern blot analysis of TGFα, EGF and EGFR were obtained from the American Type Sucrose density gradient analysis Culture Collection; a cDNA for c-fos was provided by Dr K.Ramos (Texas Nuclear extracts were layered on linear sucrose gradients (5% to 25%) A&M University, College Station, TX). Antisense hER and Arnt constructs prepared in HEGD plus 0.4 M KCl. Gradients were centrifuged at 404 000 g utilized pcDNA 3 and pcDNA 1 , respectively. at 3°C for 2.5 h. After centrifugation, 30 fractions were collected from each Cell culture maintenance and growth gradient and radioactivity in each fraction was determined to give the total binding. MDA-MB-468 human breast cancer cells were maintained in DME/F12 medium with or without phenol red and supplemented with 5% fetal bovine Northern blot analysis serum plus 10 ml antibiotic/antimycotic solution at 37°C. For routine prolifera-RNA was extracted using an RNA extraction kit purchased from TEL-TEST, tion experiments, cells were seeded at 6.0 to 7.5ϫ10 4 cells/well in 6-well Inc. (Friendswood, TX). An aliquot of 25 µg of total RNA per treatment plates. After 20 h, cells were treated with the appropriate chemicals, hormones group was separated by electrophoresis on 1.2% agarose gels, transferred onto or growth factors for specific time periods as indicated; the medium was a nylon membrane, bound to the membrane by UV cross-linking, and baked changed and cells were re-dosed every 48 h. Cells were harvested and counted at 80°C for 2 h. The membrane was then pre-hybridized in a solution using a Coulter Z1 cell counter after appropriate treatments. The studies on containing 0.1% bovine serum albumin (BSA), 0.1% Ficoll, 0.1% polythe effects of TCDD on c-myc mRNA levels utilized cells that were grown vinyl pyrolidone, 10% dextran sulfate, 1% SDS and 5ϫ SSPE (0.75 M NaCl, in serum-free media for 48 h (growth-arrested) and then treated with TCDD 50 mM NaH 2 PO 4 , 5 mM EDTA) for 18-24 h at 60°C and hybridized in the in normal serum-containing medium. For the reverse effect of EGFR antibody same buffer for 24 h with the 32 P-labeled DNA probe (10 6 c.p.m./ml). The on TCDD-mediated cell growth, cells were co-treated with 10 nM TCDD and cDNA probes were labeled with [α-32 P]dCTP. 0.25 µg/ml EGFR antibody for 6 days.
Analysis of secreted TGFα proteins by ELISA Ethoxyresorufin O-deethylase (EROD) assay
MDA-MB-468 cells were seeded in 6-well plates and grown in phenol redCells were seeded into 60-mm Petri dishes at 70% confluence and, after 24 h, free DME/F12 medium supplemented with 5% fetal calf serum to reach treated with 0.1% dimethyl sulfoxide (DMSO) (control) or 10 nM TCDD in 70% confluence. Cells were then changed to serum-free DME/F12 medium DMSO. Cells were then harvested and EROD activity was determined containing 10% BSA. Cells were then treated with 0.1% DMSO (control) and fluorometrically as previously described (17, 45) .
10 nM TCDD for 48 h; the media were changed and treatment with DMSO Transient transfection assay and TCDD was continued 24 h. Conditioned medium was collected after the last 24 h and proteins were concentrated using an Amico microconcentrator Cells were seeded in 100-mm Petri dishes and grown until 70% confluent; 5 to 10 µg of each plasmid and 20 µg polybrene/ml were used for the assays.
(Beverly, MA). Sandwich enzyme-linked immunosorbent assay (ELISA) for Fig. 3 . Effects of retinoic acid, TPA, EGF and TCDD on proliferation of significant (P Ͻ 0.05) 50% decrease in the induction of CAT activity by MDA-MB-468 cells. The cells were seeded in multi-well plates in media TCDD (see Figure 2) .
containing DME/F12 supplemented with 5% FBS and treated with DMSO b Statistically higher (P Ͻ 0.01) than DMSO-treated MDA-MB-468 cells (u, control); 1 µM retinoic acid (m); 10 ng/ml TPA (j); 10 ng/ml EGF transfected with pRNH11c.
(d) and 10 nM TCDD (s). Cell numbers were determined after 2, 4 and 6 days and results are expressed as means Ϯ SD for at least three separate determinations for each data point. Cell proliferation was significantly inhibited by TPA and TCDD but not by retinoic acid. In cells treated with 10 ng/ml EGF alone for 6 days, there was an 89% inhibition of control cell growth. treated with either DMSO (control), 10 nM TCDD, or 5 µM 8-MCDF, and Transfection with antisense ER did not affect inducibility whereas antisense cell proliferation or EROD activity was determined after 6 or 1 days, Arnt significantly (P Ͻ 0.05) decreased induction of CAT activity by respectively, as described in the Materials and methods. In the cell TCDD. In parallel experiments in MCF-7 cells, both antisense ER and Arnt proliferation experiment, the percent inhibition is compared with growth in plasmids decreased induction of CAT activity by TCDD (data not shown).
control (DMSO) cells; EROD activity in control cells was non-detectable. It (B) Cells were transiently transfected with the Vit-CAT plasmid alone was found that 10 nM TCDD was significantly more active in the growth-(lanes 1 and 2) or co-transfected with hER (lanes 3 and 4) and treated with inhibitory and EROD induction assays than a 5 µM concentration of 8-DMSO (lanes 1 and 3) or 10 nM E2 (lanes 2 and 4) as described. Relative MCDF, a weak Ah receptor agonist (32) . Similar results were observed for CAT activities in lanes 1 through 4 were 1.0, 0.9 Ϯ 0.1, 1.7 Ϯ 0.6 and a series of other weak Ah receptor agonists including 6-methyl, 6-ethyl, 6-t-4.8 Ϯ 1.2, respectively. hER significantly (P Ͻ 0.05) restored estrogenbutyl, 6-cyclohexyl and 6-propyl-1,3,8-trichlorodibenzofuran (data not responsiveness in MDA-MB-468 cells. Results are expressed as means Ϯ shown). SD for three separate determinations.
The results in Figure 3 illustrate the time-dependent effects significantly induced EROD activity (302 Ϯ 50 pmol/min per mg) and caused a 53% inhibition of cell growth, whereas a of 10 nM TCDD, TPA (10 ng/ml), and retinoic acid (1 µM) on proliferation of MDA-MB-468 cells. Retinoic acid did not 500-fold higher concentration of 8-MCDF did not induce EROD activity, and inhibited growth by 28% (compared with inhibit cell growth; however, EGF, TPA and TCDD were potent inhibitors of MDA-MB-468 cell proliferation. The DMSO-treated cells). Similar results were also observed for a series of alkyl polychlorinated dibenzofurans (PCDFs) (32) results in Figure 4 compare the structure-induction and structure-growth inhibition relationships for TCDD, a potent Ah (data not shown). These structure-activity relationships were consistent with a role for the Ah receptor in mediating both receptor agonist, and 8-methyl-1,3,6-trichlorodibenzofuran (8-MCDF), a weak Ah receptor agonist (32) . At 10 nM, TCDD the induction and growth inhibition responses in MDA-MB-fluorescence to determine the number of apoptotic cells as described (47) . Additional morphological analysis by combined phase-contrast microscopy and ethidium-bromide fluorescence ( Figure 8 ) showed that only a few apoptotic cells were observed after treatment with DMSO (control) and most non-viable cells exhibited organized chromatin structure. In the treatment groups, the increase in the number of apoptotic cells followed the order EGF Ͼ TGFα Ͼ TCDD where EGF was the most effective inducer of apoptosis with the highest levels of condensed and/or fragmented DNA (Figure 8 ).
Discussion
TCDD and structurally related Ah receptor agonists inhibit a broad spectrum of estrogen-induced responses in the rodent uterus and mammary gland, and ER-positive human breast cancer cell lines (14) . The results of the present study demonstrate that ER-negative MDA-MB-468 cells are Ah-responsive Figure 5 show that TGFα caused TCDD also induced formation of a retarded nuclear Ah a concentration-dependent inhibition of MDA-MB-468 cell receptor-DRE complex that can be observed in a gel-mobility proliferation at concentrations from 1 to 100 ng/ml.
shift assay. The ligand-induced formation of the nuclear Ah The effects of TCDD on expression of various genes and receptor complex does not define Ah-responsiveness since gene products were also determined in MDA-MB-468 cells.
previous studies have shown that this complex can be detected TCDD caused a time-dependent induction of TGFα and EGFR in Ah-non-responsive MDA-MB-231, benzo[a]pyrene-and mRNA levels and significant induction of both genes was adriamycin-resistant variant MCF-7 cells, and Hs578T human observed within 2 h after treatment with 10 nM TCDD (1.73-breast cancer cells lines (17, 34, 39, 41) . However, in contrast to and 1.74-fold induction, respectively) ( Figure 6B and C). After these cell lines, treatment of MDA-MB-468 cells with 10 nM 72 h, TGFα and EGFR mRNA levels were induced 2.86-TCDD resulted in significant induction of CYP1A1-dependent and 1.79-fold, respectively. c-myc mRNA levels ( Figure 6A) EROD activity (657 pmol/min per mg), which was higher than exhibited time-dependent changes when grown in serumobserved in any other human cancer cell line previously containing medium with maximal levels observed after 1 h; investigated in this laboratory (34) . TCDD also induced however, TCDD did not induce any significant changes in c-CAT activity (5.5-fold) in MDA-MB-468 cells transiently myc mRNA levels at any time point. Similarly, 10 nM TCDD transfected with pRNH11c, a plasmid that contains Ah-responsdid not affect c-fos or EGF mRNA levels (data not shown).
ive 5Ј-flanking DNA (-1142/ϩ2434) from the human CYP1A1 EGF mRNA was detectable only as a faint band by Northern gene fused to the bacterial CAT reporter gene (56) ( Table I ). blot analysis.
Previous studies with MDA-MB-231 and Hs578T human The results in Figure 7 demonstrate that 10 nM TCDD also breast cancer lines showed that Ah-responsiveness could be induced secretion of TGFα protein as determined in an modified by co-transfection of pRNH11c with Ah receptor, ELISA assay. Immunoreactive TGFα levels in cells treated Arnt, ER or truncated ER expression plasmids (40, 41) . The with DMSO (control) or 10 nM TCDD for 72 h were 4.8 and results of these co-transfection studies with MDA-MB-468 10.4 ng/10 6 cells or 1.79 and 5.10 ng/ml, respectively. Both cells indicate that Ah-responsiveness (i.e. TCDD-inducibility) TGFα and EGF are endogenous ligands for the EGFR and was not influenced by expression of these nuclear transcription previous studies have demonstrated that TCDD down-regulates factors; however, there was a 2-to 3-fold increase in basal EGFR binding and/or mRNA levels in a number of target and inducible CAT activities in cells co-transfected with tissues and cells (48) (49) (50) (51) (52) (53) (54) (55) . Incubation of MDA-MB-468 cells pRNH11c and the human ER expression plasmid (Table I) . with a commercially-available EGFR antibody at a concentra-
The dissociation of Ah-responsiveness from ER expression tion of 0.25 µg/ml did not affect cell growth whereas higher was further investigated by co-transfecting MDA-MB-468 concentrations of the antibody alone inhibited cell growth cells with pRNHIIc plus antisense hER (Figure 2A, lanes 3  (data not shown) . The results presented in Figure 7 demonstrate and 4) or antisense Arnt (Figure 2A, lane 5) . Antisense ER that the growth inhibitory effects of 10 nM TCDD were did not affect Ah-responsiveness of MDA-MB-468 cells, reversed by the EGFR antibody.
whereas in comparable experiments in MCF-7 cells, antisense Previous studies reported that EGF induced apoptosis in hER expression decreased induction of CAT activity by TCDD MDA-MB-468 cells. Therefore, the comparative effects of (data not shown). As a positive control, it was shown that co-10 nM TCDD, EGF (10 ng/ml) and TGFα (10 ng/ml) on transfection with antisense Arnt (Figure 2A , lane 5) resulted induction of apoptosis in MDA-MB-468 cells was investigated using phase contrast acridine orange and ethidium bromide in a 50% decrease in induction of CAT activity by TCDD and this is consistent with a role for the heterodimeric nuclear Ah E2 in MDA-MB-468 cells transiently transfected with the Vit-CAT plasmid ( Figure 2B , lane 2), whereas in cells coreceptor complex in mediating this induction response.
Previous studies have shown that there was a correlation transfected with hER, estrogen-responsiveness was restored ( Figure 2B, lanes 3 and 4) . These results further confirm the between Ah-and estrogen-responsiveness in human breast cancer cell lines (33). Therefore, the presence or absence of ER-negative phenotype of this cell line (58) and, therefore, MDA-MB-468 cells represent a unique ER-negative:Ah the ER in MDA-MB-468 cells was further investigated. After treatment of the cells with [ 3 H]E2 for 2 h, a radiolabeled receptor-positive breast cancer cell line. TCDD and related Ah receptor agonists inhibit E2-induced nuclear ER was not detected by velocity sedimentation analysis; whereas a 5.4 S nuclear ER was detected in ER-positive MCFgene expression and growth of ER-positive breast cancer cells (14) and therefore the second phase of this study focused on 7 cells that were used as positive control (data not shown). The results in Figure 1 also show the minimal wild-type ER the potential antiproliferative activity of TCDD in MDA-MB-468 cells and the mechanism of this response. The results in mRNA transcript ( Figure 1B, lane 2) or immunoreactive protein ( Figure 1B, lane 2) were detected in MDA-MB-468 Figure 3 compare the antimitogenic activities of TCDD, TPA, EGF and retinoic acid; retinoic acid did not significantly inhibit cells, whereas relatively high levels were observed in E2-responsive MCF-7 cells ( Figure 1A and B, lane 1) . These cell proliferation and this was consistent with low expression of the retinoic acid receptor ' expression in MDA-MB-468 results suggest that Ah-responsiveness in MDA-MB-468 cells is ER-independent and contrasts with results of previous studies cells (59) . Previous studies have shown that EGF inhibits proliferation of MDA-MB-468 cells (60) (61) (62) (63) and this was (33,40,41). E2-non-responsiveness of MDA-MB-468 cells was further confirmed in transient transfection studies utilizing confirmed in the present study ( Figure 3 ). The results also showed that TCDD was a potent inhibitor of cell proliferation. the Vit-CAT plasmid derived from the 5Ј-flanking of the vitellogenin A2 gene (57) . CAT activity was not induced by
The results summarized in Figure 4 show that TCDD, a potent Ah receptor agonist, is more active than 8-MCDF, a less potent agonist, in both the growth inhibition ( Figure 4A ) and induction ( Figure 4B ) assays in MDA-MB-468 cells, and similar results were observed with a series of other 6-alkyl-1,3,8-trichlorodibenzofurans that are relatively non-toxic Ah receptor agonists (32) . The structure-dependent inhibition of MDA-MB-468 cell growth by TCDD and related compounds is consistent with an interaction between the Ah receptor and signaling pathways associated with cell proliferation. Previous studies have reported that cytotoxic drugs inhibit growth of these cells (60) (61) (62) (63) (64) and EGF, a polypeptide that stimulates growth of several breast cancer cell lines, also inhibits proliferation of MDA-MB-468 cells (60) (61) (62) (63) . The inhibition of cell growth by EGF is accompanied by increased expression of EGFR, c-myc and induces proliferation of ER-positive breast cancer cell lines (7) (8) (9) . TGFα mRNA has previously been detected in MDA-MB-468 cells and conditioned media from this cell line competes with EGF for binding to the EGFR (61) . TGFα inhibits growth of MDA-MB-468 cells ( Figure 5 ) and the results summarized in Figures 6C and 7 show that TCDD induces TGFα mRNA and secreted immunoreactive protein levels. The time-dependent induction of mRNA ( Figure 6C ) by TCDD has also been previously observed in human keratinocytes (66) . Further confirmation of the role of TGFα in the inhibition of MDA-MB-468 cell proliferation by TCDD was obtained using EGFR antibodies that block ligand binding to this cell membrane receptor. At high antibody concentrations, there was inhibition of cell growth (data not shown) as previously reported (61); however, at an EGFR antibody concentration of 0.25 µg/ml, cell growth was not significantly inhibited and, in cells co-treated with 10 nM TCDD plus EGFR antibody, the antimitogenic activity of TCDD was significantly inhibited (Figure 7 ). These results suggest that induction of TGFα by TCDD is associated with the growthinhibitory activity of TCDD in MDA-MB-468 cells. The antiproliferative activity of TGFα observed in MDA-MB-468 
